Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.
about
Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipientsManagement of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignanciesFourth European Conference on Infections in Leukaemia (ECIL-4): guidelines for diagnosis and treatment of human respiratory syncytial virus, parainfluenza virus, metapneumovirus, rhinovirus, and coronavirusRespiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment.Challenges and opportunities in developing respiratory syncytial virus therapeuticsGS-5806 Inhibits a Broad Range of Respiratory Syncytial Virus Clinical Isolates by Blocking the Virus-Cell Fusion ProcessAdvances in antivirals for non-influenza respiratory virus infections.Respiratory syncytial virus lower respiratory disease in hematopoietic cell transplant recipients: viral RNA detection in blood, antiviral treatment, and clinical outcomesAdenoviral infections in adult allogeneic hematopoietic SCT recipients: a single center experience.Nosocomial transmission of respiratory syncytial virus in an outpatient cancer center.Immunodeficiency scoring index to predict poor outcomes in hematopoietic cell transplant recipients with RSV infectionsContributing and Terminating Factors of a Large RSV Outbreak in an Adult Hematology and Transplant Unit.A Numerically Subdominant CD8 T Cell Response to Matrix Protein of Respiratory Syncytial Virus Controls Infection with Limited Immunopathology.An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infectionClinical utility of a near patient care microarray based diagnostic test for influenza and respiratory syncytial virus infections.Management of respiratory viral infections in hematopoietic cell transplant recipients.Molecular characterization of a respiratory syncytial virus outbreak in a hematology unit in Heidelberg, Germany.Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.Clinical outcomes in outpatient respiratory syncytial virus infection in immunocompromised children.Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement.How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantationMortality rates of human metapneumovirus and respiratory syncytial virus lower respiratory tract infections in hematopoietic cell transplantation recipients.Diagnosis and treatment of viral diseases in recipients of allogeneic hematopoietic stem cell transplantation.Prophylactic and therapeutic testing of Nicotiana-derived RSV-neutralizing human monoclonal antibodies in the cotton rat model.Respiratory syncytial virus in hematopoietic cell transplant recipients: factors determining progression to lower respiratory tract disease.A review of palivizumab and emerging therapies for respiratory syncytial virus.Prophylaxis and treatment of respiratory syncytial virus in adult immunocompromised patients.Oral Ribavirin for the Treatment of Noninfluenza Respiratory Viral Infections: A Systematic Review.Prevention of viral infections in patients with multiple myeloma: the role of antiviral prophylaxis and immunization.Antiviral therapy for respiratory viral infections in immunocompromised patients.Viral Pneumonia in Patients with Hematologic Malignancy or Hematopoietic Stem Cell Transplantation.Respiratory syncytial virus pneumonia treated with lower-dose palivizumab in a heart transplant recipient.Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo.Respiratory virus infection after allogeneic hematopoietic stem cell transplant in a tropical center: Predictive value of the immunodeficiency scoring index.Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative.Corticosteroid use as adjunct therapy for respiratory syncytial virus infection in adult allogeneic stem cell transplant recipients.A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study.Investigation of Respiratory Syncytial Virus Outbreak on an Adult Stem Cell Transplant Unit using Whole Genome Sequencing.Severe viral pneumonia in adults: what is important for the ICU physician?[Fever, coughing and dyspnea in a 38-year-old female kidney transplant recipient].
P2860
Q26829188-123551EC-1461-4535-AC82-99108BE704FEQ26853131-AD3DD5DD-0B67-4D0A-A9E6-05AECF828A91Q27021622-18749DE2-75E5-48C1-A443-1ED3A3A4751BQ30240274-0573D14B-F21E-476C-A262-B29C690E06B1Q30300567-41D82647-0026-41D6-B848-3D67CAB2EBBAQ30375062-5F3BA9C3-7AC8-4F97-BBAF-60D8658B8C37Q30457132-EC9FB7B3-FDA5-4CBC-84A6-B53E8AFF7554Q33410539-6F0F550F-D54D-4D68-AE5B-6092E022544CQ33566426-64C7F994-BF4F-4F28-8831-38704B42CC02Q33677479-8FD6CB8C-4DB5-40CA-8919-A2E5F5D36A07Q33714717-31AA4599-38D6-4670-8ACB-9FFCD0DD9730Q34214867-8BC73198-ECC6-413C-A6C6-90025FCC8D56Q35946229-3CAEFCEC-C29F-4BC1-9A00-31096E5B418AQ36305453-FB704402-B1F6-48F9-BDD9-56574FB88935Q36318050-B8D21289-28CE-4389-865D-79A4FF6DA0E7Q36439896-EE7DE7FF-59D6-439D-9FB8-C859BD25FB15Q36506275-659A496C-6ED6-4893-9CD3-0495C2042858Q36558322-0D7A4A5B-18FE-4169-8ACC-AB83701A41A0Q36748198-C00B812C-1E48-4E59-B3CB-7E6ACE8BAB75Q36886930-723CE464-CC86-47E2-B0D6-EB1DD7404ECDQ36965855-517A54AA-196D-4AC9-977A-65AB3979E01CQ37118406-B654FABB-23EE-484E-A5D7-5286018D84CAQ37426542-6EB36F17-9BDD-45D6-8423-705C3A9613A1Q37484236-D6F7F4D8-481B-45DF-9BAC-0262C2281BCBQ37671949-637BE51B-2822-4487-99BF-C66F80C799EFQ37914882-9F2B9557-FA91-4FA3-A8C9-2B1EBC43C771Q37991125-9C24E970-6E94-4E50-9079-9EE8E65F87D5Q38558150-FE4C8187-2473-4E8D-8A05-7260C7D7101AQ38613285-BAFB80B3-2DF1-4C30-8D23-95DA303DF9E2Q39076394-A76F4224-42AB-4FB7-9066-F3385CB53BFBQ39118448-3E1D1174-4D51-4E0F-995C-CDADDAE28E82Q39171120-915BC5DC-9649-4A63-AD18-96513AA27620Q39205730-CCB87931-BA4C-4581-8D07-7E61D0CAAF6BQ39574491-BD6200C3-3C6A-493D-91E7-2B101611ACC0Q39962070-2B72A774-28A8-4501-A35D-CCECAD7FC0A5Q39973043-83DAA915-FDB6-4392-B051-2DD1A298F3BAQ40055495-41666231-B456-49FE-9D25-ED43F4075DE9Q40107120-467DB944-0947-4439-9A78-5C7B04B570C5Q40152480-3E8F9AAA-DB47-4FBA-9D6B-77C917FD2246Q40270025-4EFBF4F2-02F4-47AA-B298-4CCECA7C825F
P2860
Management of RSV infections in adult recipients of hematopoietic stem cell transplantation.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 07 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Management of RSV infections i ...... tic stem cell transplantation.
@en
Management of RSV infections i ...... tic stem cell transplantation.
@nl
type
label
Management of RSV infections i ...... tic stem cell transplantation.
@en
Management of RSV infections i ...... tic stem cell transplantation.
@nl
prefLabel
Management of RSV infections i ...... tic stem cell transplantation.
@en
Management of RSV infections i ...... tic stem cell transplantation.
@nl
P1433
P1476
Management of RSV infections i ...... tic stem cell transplantation.
@en
P2093
Jharna N Shah
Roy F Chemaly
P304
P356
10.1182/BLOOD-2010-08-263400
P407
P577
2010-12-07T00:00:00Z